NCT01904253 2024-09-05
A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy
Taiho Oncology, Inc.
Phase 2 Terminated
Clinical Trials
3 trialsNCT00286169 2022-04-12
Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC)
Sumitomo Pharma Co., Ltd.
Phase 3 Terminated
NCT01331824 2018-04-23
Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial Carcinoma
Icahn School of Medicine at Mount Sinai
Phase 2 Terminated